Reports

Sale

Companion Animal Vaccine Market

Global Companion Animal Vaccine Market Size, Forecast: By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Subunit Vaccine, Conjugate Vaccine, DNA Vaccine, Others; By Animal Type: Feline, Others; By Disease; By Distribution Channel; Regional Analysis; Competitive Landscape; 2024-2032

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Companion Animal Vaccines Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Companion Animal Vaccines Historical Market (2018-2023) 
    8.3    Global Companion Animal Vaccines Market Forecast (2024-2032)
    8.4    Global Companion Animal Vaccines Market by Vaccines
        8.4.1    Live Attenuated Vaccines
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Inactivated Vaccines 
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032) 
        8.4.3    Toxoid Vaccines
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Recombinant Vaccines
            8.4.4.1    Historical Trend (2018-2023)
            8.4.4.2    Forecast Trend (2024-2032)
        8.4.5    Subunit Vaccine
            8.4.5.1    Historical Trend (2018-2023)
            8.4.5.2    Forecast Trend (2024-2032)
        8.4.6    Conjugate Vaccine
            8.4.6.1    Historical Trend (2018-2023)
            8.4.6.2    Forecast Trend (2024-2032)
        8.4.7    DNA Vaccine
            8.4.7.1    Historical Trend (2018-2023)
            8.4.7.2    Forecast Trend (2024-2032)
        8.4.8    Others 
    8.5    Global Companion Animal Vaccines Market by Animal Type
        8.5.1    Feline
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Canine
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Bovine
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Others
    8.6    Global Companion Animal Vaccines Market by Disease
        8.6.1    Rabies
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Hepatitis
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Leukemia
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Others
    8.7    Global Companion Animal Vaccines Market by Distribution Channel
        8.7.1    Veterinary Clinics
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Veterinary Hospitals 
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032) 
        8.7.3    Veterinary Research Institutes
            8.7.3.1    Historical Trend (2018-2023)
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Retail Pharmacies
            8.7.4.1    Historical Trend (2018-2023)
            8.7.4.2    Forecast Trend (2024-2032)
        8.7.5    Others   
    8.8    Global Companion Animal Vaccines Market by Region
        8.8.1    North America
            8.8.1.1    Historical Trend (2018-2023) 
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Europe
            8.8.2.1    Historical Trend (2018-2023) 
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Asia Pacific
            8.8.3.1    Historical Trend (2018-2023) 
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Latin America
              8.8.4.1    Historical Trend (2018-2023) 
              8.8.4.2    Forecast Trend (2024-2032)
        8.8.5    Middle East and Africa
            8.8.5.1    Historical Trend (2018-2023) 
            8.8.5.2    Forecast Trend (2024-2032)
9    North America Companion Animal Vaccines Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Companion Animal Vaccines Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Companion Animal Vaccines Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Companion Animal Vaccines Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Companion Animal Vaccines Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive  Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Boehringer Ingelheim
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Intervet Inc. (Merck Animal Health)
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Zoetis Services LLC
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Bioveta, a.s.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Elanco Animal Health Incorporated
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Zoetis Inc
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Others
16    Key Trends and Developments in the Market

 

List of Figures and Tables

1.    Global Companion Animal Vaccines Market: Key Industry Highlights, 2017 and 2021
2.    Global Companion Animal Vaccines Historical Market: Breakup by Vaccines (USD Million), 2018-2023
3.    Global Companion Animal Vaccines Market Forecast: Breakup by Vaccines (USD Million), 2024-2032
4.    Global Companion Animal Vaccines Historical Market: Breakup by Animal Type (USD Million), 2018-2023
5.    Global Companion Animal Vaccines Market Forecast: Breakup by Animal Type (USD Million), 2024-2032
6.    Global Companion Animal Vaccines Historical Market: Breakup by Disease (USD Million), 2018-2023
7.    Global Companion Animal Vaccines Market Forecast: Breakup by Disease (USD Million), 2024-2032
8.    Global Companion Animal Vaccines Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
9.    Global Companion Animal Vaccines Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
10.    Global Companion Animal Vaccines Historical Market: Breakup by Region (USD Million), 2018-2023
11.    Global Companion Animal Vaccines Market Forecast: Breakup by Region (USD Million), 2024-2032
12.    North America Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2018-2023
13.    North America Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Europe Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Europe Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Asia Pacific Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Asia Pacific Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Latin America Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2018-2023
19.    Latin America Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Middle East and Africa Companion Animal Vaccines Historical Market: Breakup by Country (USD Million), 2018-2023
21.    Middle East and Africa Companion Animal Vaccines Market Forecast: Breakup by Country (USD Million), 2024-2032
22.    Global Companion Animal Vaccines Market Structure

Key Questions Answered in the Report

The global companion animal vaccine market is projected to grow at a CAGR of 6.2% between 2024 and 2032.

The major drivers of the market include the economic development, associated increase in disposable income, rise in pet ownership, expenditure on pet care, and advancements in animal health medicines, vaccines.

The growing rate of adoption of companion animals and advancements in treatment systems are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different vaccines in the market are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, subunit vaccine, conjugate vaccine, and DNA vaccine, among others.

Based on animal type, the market is divided into feline, canine, and bovine, among others.

The various diseases in the market are rabies, hepatitis, and leukemia, among others.

The several distribution channels are veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies, among others.

The major players in the industry are Boehringer Ingelheim, Intervet Inc. (Merck Animal Health), Zoetis Services LLC, Bioveta, a.s., Elanco Animal Health Incorporated, and Zoetis Inc, among others.

Analyst Review

The global companion animal vaccine market was driven by the growing rate of adoption of companion animals in the historical period. Aided by the rise in pet ownership and advancements in treatment systems, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 6.2%.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The different vaccines in the market are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, subunit vaccine, conjugate vaccine, and DNA vaccine, among others. Based on animal type, the market is divided into feline, canine, and bovine, among others. The various diseases in the market are rabies, hepatitis, and leukemia, among others. The several distribution channels are veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies, among others. The major regional markets for companion animal vaccine are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are Boehringer Ingelheim, Intervet Inc. (Merck Animal Health), Zoetis Services LLC, Bioveta, a.s., Elanco Animal Health Incorporated, and Zoetis Inc, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Datasheet

$ 2199     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3299     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4399     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5499     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER